Biota Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

BOTA 2.09 0.00 (0.00%)
price chart
Biota Pharmaceuticals, Inc. (BOTA) Files Form 4 Insider Buying : Anne Vanlent ...
Biota Pharmaceuticals, Inc. (BOTA): Anne Vanlent , director of Biota Pharmaceuticals, Inc. purchased 35,000 shares on Jun 22, 2015.
Insider Buying: Biota Pharmaceuticals Director Anne Vanlent Buys 35000 ...  WKRB News
Biota Pharmaceuticals, Inc. (BOTA) Discloses Form 4 Insider Buying : Exec ...
Biota Pharmaceuticals, Inc. (BOTA) Discloses Insider Transaction. Anne Vanlent , director of Biota Pharmaceuticals, Inc. purchased 35,000 shares on Jun 22, 2015. The Insider buying transaction was disclosed on Jun 24, 2015 to the Securities and ...
Biota Pharmaceuticals, Inc. (BOTA) Files Form 4 Insider Buying : James Fox ...
Biota Pharmaceuticals, Inc. (BOTA): James Fox , director of Biota Pharmaceuticals, Inc. purchased 70,000 shares on Jun 10, 2015.
Biota Pharmaceuticals Inc Stock Downgraded (BOTA)
The gross profit margin for BIOTA PHARMACEUTICALS INC is currently lower than what is desirable, coming in at 34.92%. It has decreased significantly from the same period last year.
Related articles »  
What after Joseph Patti's Insider Purchase of Biota Pharmaceuticals Inc ...
Joseph Patti; that is an insider in Biota Pharmaceuticals Inc (NASDAQ:BOTA) 2.14 -0.02 -0.93% who is the latest to obtain shares in the firm for which he is the current CEO.
Biota Pharmaceuticals Completes Acquisition of Anaconda Pharma
ATLANTA, June 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals (Nasdaq:BOTA) ("Biota" or the "Company") announced today that it has completed the acquisition of Anaconda Pharma, a privately-held biotechnology company based in Paris, France.
Biota Pharmaceuticals to Acquire Anaconda Pharma
ATLANTA, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals (Nasdaq:BOTA) (the "Company") announced today that it has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held biotechnology company based in Paris, ...
Biota to Acquire Anaconda Pharma for Up-to-$38M  Genetic Engineering & Biotechnology News
Form 8-K Biota Pharmaceuticals, For: Jun 03
On June 3, 2015, Biota Pharmaceuticals, Inc. (the “Company”) consummated the acquisition (the “Acquisition”) of all of the outstanding shares of Anaconda Pharma (“Anaconda”) pursuant to the terms and conditions of the Stock Purchase Agreement (the ...
Biota Pharmaceuticals: Recent Progress Illustrates Buying Opportunity Remains ...
While the termination of the BARDA contract in April 2014 that provided up $231 million for the development of laninamivir octanoate had a substantial negative effect on Biota in 2014 as it took away a source of major funding, the company has made ...
Massive Swings: Biota Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Healthcare investors were presented with major movements in two small stocks today: Amicus Therapeutics (NASDAQ: FOLD ) popped almost 21% on strong phase 3 data for a Fabry disease drug, while Biota Pharmaceuticals (NASDAQ: BOTA ) collapsed ...
Related articles »